Enteral nutrition refers to delivery of food containing carbohydrates, proteins, water, fat, minerals, and vitamins in the body through the gastrointestinal tract with the help of feeding tubes. It is imperative for patients to have a functional gastrointestinal tract however, patients are unable to maintain safe or adequate oral intake. Furthermore, a nasoenteral tube passes through the nasal cavity and into the stomach. When a tube is passed through the skin into the stomach it is called gastrostomy. Such tubes help patients, who are unable to consume normally, to ingest food.
Market Dynamics
Technological advancement in the field of enteral nutrition therapy and product launches by key players operating in the market is expected to drive the market growth over the forecast period. For instance, in February 2017, Baxter International Inc. announced the launch of a new enteral ENFit syringe and accessory for patients requiring tube feeding. Baxter’s enteral ENFit syringe is a technologically advanced product designed to improve patient safety during enteral nutrition (EN) therapy by preventing misconnections or wrong-route administration that can cause severe patient injury.
Key features of the study:
- This report provides in-depth analysis of the Brazil enteral nutrition market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Brazil enteral nutrition market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Abbott Laboratories, Prodiet Nutrição Clínica, Nestlé S.A., Danone, Royal Friesland Campina, Baxter International Inc., Nutrimed, B. Braun Melsungen AG, Pfizer, Inc., Reckitt Benckiser Group plc, Eurofarma, Nuteral, Fresenius Kabi AG, and Nutricium
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The Brazil enteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the brazil enteral nutrition market
Detailed Segmentation:
- Brazil Enteral Nutrition Market, By Protein Composition:
- Standard Protein Diet
- High Protein Supplement
- Protein for Diabetes Care Patient
- Others
- Brazil Enteral Nutrition Market, By Application:
- Nutrition Source
- Pediatric Nutrition
- Adult and Elderly Nutrition
- Sports Nutrition
- Disease Specific
- Diabetes
- Cancer
- Obesity
- Allergy Management
- Others
- Brazil Enteral Nutrition Market, By Distribution Channel:
- Hospitals
- Retail Channel
- Government Institutes and Other Public Institutes
- Online Channel
- Brazil Enteral Nutrition Market, By Packaging:
- Ready to Drink
- Ready to Hang
- Powder
- Bolus
- Others
- Company Profiles
- Abbott Laboratories *
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Prodiet Nutrição Clínica
- Nestlé S.A.
- Danone
- Royal Friesland Campina
- Baxter International Inc.
- Nutrimed
- Braun Melsungen AG
- Pfizer, Inc.
- Reckitt Benckiser Group plc
- Eurofarma
- Nuteral
- Fresenius Kabi AG
- Nutricium
“*” marked represents similar segmentation in other categories in the respective section.
